TLDR
- On September 24, 2026, Iridium shareholders overwhelmingly endorsed Rocket Lab’s takeover bid with 99.6% voting approval.
- Around 81% of all outstanding Iridium shares participated in the special stockholder meeting vote.
- Iridium’s valuation under the agreement stands at $54.00 per share, structured as a combination of cash and RKLB equity.
- RKLB shares surged 5% to reach $73.61 that day, supported by a Space Force contract announcement and ARK Invest share purchases.
- Deal completion is targeted for mid-2027, subject to regulatory clearances and standard closing requirements.
Rocket Lab (RKLB) shares advanced 5% Thursday, settling around $73.61 after touching an intraday peak of $75.46. The rally coincided with a significant development in the company’s planned takeover of satellite communications provider Iridium Communications (IRDM).
During a special meeting held September 24, Iridium’s shareholders delivered resounding support for the acquisition. Nearly 99.6% of ballots cast endorsed the transaction, with participation from approximately 81% of the company’s total outstanding stock.
Meeting attendees also gave the green light to an advisory measure addressing golden parachute payments for senior executives. These dual approvals eliminate a significant obstacle on the path to transaction completion.
The agreement’s structure provides Iridium investors with $27.00 cash per share alongside Rocket Lab equity determined through a collared exchange mechanism. Total consideration per Iridium share reaches a notional $54.00.
Peter Beck, Rocket Lab’s CEO, characterized the vote as “an important milestone” toward establishing what he termed a next-generation aerospace leader. Iridium’s CEO Matt Desch shared similar enthusiasm, emphasizing how the two organizations’ strengths align strategically.
Completion of the combination is anticipated by mid-2027, contingent upon regulatory approvals and standard transaction closing requirements.
Additional Catalysts Behind RKLB’s Weekly Performance
Separate from the Iridium development, Rocket Lab secured inclusion on the Space Force’s NITE-STAR contracting platform. This framework carries a maximum potential worth of $981 million extending through 2036, although the company has no guaranteed allocation from that total pool.
ARK Invest accumulated approximately $25 million in Rocket Lab equity across its portfolio funds during the week. Fund manager Cathie Wood has consistently added to her RKLB position throughout this year.
Market dynamics may also favor the company. SpaceX reportedly plans to reduce its third-party rideshare launch capacity, potentially creating new opportunities for alternative launch service providers including Rocket Lab.
Thursday’s session saw robust trading activity. Volume reached nearly 25 million shares, representing an 8% increase over the typical daily average of approximately 23.2 million shares.
Wall Street Maintains Divided Outlook
Analyst sentiment on Rocket Lab remains fragmented. The stock holds a “Moderate Buy” consensus designation with a mean price objective of $107.32, based on MarketBeat data.
Piper Sandler established a “neutral” stance with an $83.00 target in July. Stifel Nicolaus projected a more optimistic $132.00 valuation in June, whereas Wall Street Zen shifted to a “sell” recommendation in August.
Several market participants have raised concerns regarding the Iridium transaction. Key risk factors cited include capital requirements, post-merger integration challenges, and potential valuation strain given RKLB’s current multiples.
Rocket Lab has yet to achieve profitability. Last quarter delivered an $0.08 per share loss that fell short of analyst projections, although revenue of $234.07 million exceeded forecasts.
Insider transactions have accelerated recently. CEO Peter Beck divested over 1.29 million shares in July, generating approximately $110 million in proceeds and reducing his ownership position by roughly 32%.
Institutional accumulation continues simultaneously. Andra AP fonden expanded its Rocket Lab position by more than 2,500% during the second quarter.
Iridium’s shares edged up 1% after the vote disclosure. The latest analyst assessment on IRDM reflects a “Hold” designation with a $54.00 target price, aligning precisely with the transaction’s notional valuation.





